{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:58:14Z","timestamp":1791147494463,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T00:00:00Z","timestamp":1313366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1756-8722-4-34","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T06:57:52Z","timestamp":1313477872000},"source":"Crossref","is-referenced-by-count":40,"title":["Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy"],"prefix":"10.1186","volume":"4","author":[{"given":"Yu Ri","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Seok","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Seong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June-Won","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,15]]},"reference":[{"key":"168_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.blre.2007.03.001","volume":"21","author":"KJ Savage","year":"2007","unstructured":"Savage KJ: Peripheral T-cell lymphomas. Blood reviews. 2007, 21: 201-216. 10.1016\/j.blre.2007.03.001.","journal-title":"Blood reviews"},{"key":"168_CR2","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D: International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. Journal of clinical oncology. 2008, 26: 4124-4130.","journal-title":"Journal of clinical oncology"},{"key":"168_CR3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1136\/jcp.2008.055335","volume":"61","author":"C Agostinelli","year":"2008","unstructured":"Agostinelli C, Piccaluga PP, Went P, Rossi M, Gazzola A, Righi S, Sista T, Campidelli C, Zinzani PL, Falini B, Pileri SA: Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. Journal of Clinical Pathology. 2008, 61: 1160-1167. 10.1136\/jcp.2008.055335.","journal-title":"Journal of Clinical Pathology"},{"key":"168_CR4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","volume":"107","author":"MA Rizvi","year":"2006","unstructured":"Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST: T-cell non-Hodgkin lymphoma. Blood. 2006, 107: 1255-1264. 10.1182\/blood-2005-03-1306.","journal-title":"Blood"},{"key":"168_CR5","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/cncr.20999","volume":"103","author":"MP Escaln","year":"2005","unstructured":"Escaln MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL, Dang NH: Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Cancer. 2005, 103: 2091-2098. 10.1002\/cncr.20999.","journal-title":"Cancer"},{"key":"168_CR6","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Morabito F, Martelli M, Brusamolino E, Iannitto E: Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004, 103: 2474-2479. 10.1182\/blood-2003-09-3080.","journal-title":"Blood"},{"key":"168_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/annonc\/mdq359","volume":"22","author":"G Gutirrez-Garca","year":"2011","unstructured":"Gutirrez-Garca G, Garca-Herrera A, Cardesa T, Martnez A, Villamor N, Ghita G, Martnez-Trillos A, Colomo L, Setoain X, Rodrguez S: Comparison of four prognostic scores in peripheral T-cell lymphoma. Annals of oncology. 2011, 22: 397-404. 10.1093\/annonc\/mdq359.","journal-title":"Annals of oncology"},{"key":"168_CR8","doi-asserted-by":"crossref","first-page":"811a","DOI":"10.1182\/blood.V106.11.811.811","volume":"106","author":"JM Vose","year":"2005","unstructured":"Vose JM: International Peripheral T-Cell Lymphoma (PTCL) Clinical and Pathologic Review Project: Poor Outcome by Prognostic Indices and Lack of Efficacy with Anthracyclines. Blood. 2005, 106: 811a-","journal-title":"Blood"},{"key":"168_CR9","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. The New England journal of medicine. 1993, 329: 987-994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"168_CR10","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1158\/1078-0432.CCR-04-0269","volume":"10","author":"B Martinez Delgado","year":"2004","unstructured":"Martinez Delgado B, Melndez B, Cuadros M, Alvarez J, Castrillo JM, Ruiz De La Parte A, Mollejo M, Bellas C, Diaz R, Lombarda L: Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clinical cancer research. 2004, 10: 4971-4982. 10.1158\/1078-0432.CCR-04-0269.","journal-title":"Clinical cancer research"},{"key":"168_CR11","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","volume":"19","author":"B Martnez-Delgado","year":"2005","unstructured":"Martnez-Delgado B, Cuadros M, Honrado E, Ruiz de la Parte A, Roncador G, Alves J, Castrillo JM, Rivas C, Bentez J: Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia. 2005, 19: 2254-2263. 10.1038\/sj.leu.2403960.","journal-title":"Leukemia"},{"key":"168_CR12","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1182\/blood-2007-02-075036","volume":"110","author":"C Rodrguez-Antona","year":"2007","unstructured":"Rodrguez-Antona C, Leskel S, Zajac M, Cuadros M, Alvs J, Moneo MV, Martn C, Cigudosa JC, Carnero A, Robledo M: Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas. Blood. 2007, 110: 3345-3351. 10.1182\/blood-2007-02-075036.","journal-title":"Blood"},{"key":"168_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2141.2008.07028.x","volume":"141","author":"MC Cox","year":"2008","unstructured":"Cox MC, Nofroni I, Laverde G, Ferrari A, Amodeo R, Tatarelli C, Saltarelli F, Veggia B, Aloe-Spiriti MA, Ruco L, Monarca B: Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma. British journal of haematology. 2008, 141: 265-268. 10.1111\/j.1365-2141.2008.07028.x.","journal-title":"British journal of haematology"},{"key":"168_CR14","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1080\/10428190802226425","volume":"49","author":"MC Cox","year":"2008","unstructured":"Cox MC, Nofroni I, Ruco L, Amodeo R, Ferrari A, La Verde G, Cardelli P, Montefusco E, Conte E, Monarca B, Aloe-Spiriti MA: Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma. Leukemia & lymphoma. 2008, 49: 1745-1751. 10.1080\/10428190802226425.","journal-title":"Leukemia & lymphoma"},{"key":"168_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1600-0609.2008.01129.x","volume":"81","author":"Y Oki","year":"2008","unstructured":"Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y, Morishima Y: Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab. European journal of haematology. 2008, 81: 448-453. 10.1111\/j.1600-0609.2008.01129.x.","journal-title":"European journal of haematology"},{"key":"168_CR16","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1038\/sj.leu.2404780","volume":"21","author":"DH Kim","year":"2007","unstructured":"Kim DH, Baek JH, Chae YS, Kim YK, Kim HJ, Park YH, Song HS, Chung JS, Hyun MS, Sohn SK: Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma. Leukemia. 2007, 21: 2227-2230. 10.1038\/sj.leu.2404780.","journal-title":"Leukemia"},{"key":"168_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2141.2007.06596.x","volume":"137","author":"D Behl","year":"2007","unstructured":"Behl D, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, Inwards DJ, White WL, Ansell SM, Micallef IN: Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas. British journal of haematology. 2007, 137: 409-415. 10.1111\/j.1365-2141.2007.06596.x.","journal-title":"British journal of haematology"},{"key":"168_CR18","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I: Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer research. 2009, 69: 5383-5391. 10.1158\/0008-5472.CAN-08-3845.","journal-title":"Cancer research"},{"key":"168_CR19","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. The New England journal of medicine. 1998, 339: 1506-1514. 10.1056\/NEJM199811193392104.","journal-title":"The New England journal of medicine"},{"key":"168_CR20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/leu.2010.108","volume":"24","author":"LF Porrata","year":"2010","unstructured":"Porrata LF, Rsitow K, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Habermann TM, Witzig TE, Colgan JP, Nowakowski GS: Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma. Leukemia. 2010, 24: 1343-1349. 10.1038\/leu.2010.108.","journal-title":"Leukemia"},{"key":"168_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ajh.21337","volume":"84","author":"LF Porrata","year":"2009","unstructured":"Porrata LF, Ristow K, Habermann TM, Witzig TE, Inwards DJ, Markovic SN: Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma. American journal of hematology. 2009, 84: 93-97. 10.1002\/ajh.21337.","journal-title":"American journal of hematology"},{"key":"168_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/annonc\/mdq314","volume":"22","author":"JJ Huang","year":"2011","unstructured":"Huang JJ, Jiang WQ, Lin TY, Huang Y, Xu RH, Huang HQ, Li ZM: Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer\/T-cell lymphoma, nasal type. Annals of oncology. 2011, 22: 149-155.","journal-title":"Annals of oncology"},{"key":"168_CR23","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lpez A, Hagenbeek A: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. Journal of clinical oncology. 1999, 17: 1244-1244.","journal-title":"Journal of clinical oncology"},{"key":"168_CR24","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","volume":"117","author":"D Weisenburger","year":"2011","unstructured":"Weisenburger D, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, Maclennan KA, Rdiger T, Pileri S, Nakamura S, Nathwani B: Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011, 117: 3402-3408. 10.1182\/blood-2010-09-310342.","journal-title":"Blood"},{"key":"168_CR25","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3109\/10428194.2010.508189","volume":"51","author":"J Castillo","year":"2010","unstructured":"Castillo J, Morales D, Quinones P, Cotrina E, Desposorio C, Beltran B: Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leukemia & lymphoma. 2010, 51: 1822-1828. 10.3109\/10428194.2010.508189.","journal-title":"Leukemia & lymphoma"},{"key":"168_CR26","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","volume":"16","author":"SC Kao","year":"2010","unstructured":"Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, Clarke SJ: High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clinical cancer research. 2010, 16: 5805-5813. 10.1158\/1078-0432.CCR-10-2245.","journal-title":"Clinical cancer research"},{"key":"168_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.imbio.2009.06.014","volume":"214","author":"C Porta","year":"2009","unstructured":"Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A, Sica A: Cellular and molecular pathways linking inflammation and cancer. Immunobiology. 2009, 214: 761-777. 10.1016\/j.imbio.2009.06.014.","journal-title":"Immunobiology"},{"key":"168_CR28","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/annonc\/mdm110","volume":"18","author":"A Plonquet","year":"2007","unstructured":"Plonquet A, Haioun C, Jais JP, Debard AL, Salles G, Bene MC, Feugier P, Rabian C, Casasnovas O, Labalette M: Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma. Annals of oncology. 2007, 18: 1209-1215. 10.1093\/annonc\/mdm110.","journal-title":"Annals of oncology"},{"key":"168_CR29","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/cncr.20688","volume":"101","author":"C Borg","year":"2004","unstructured":"Borg C, Ray Coquard I, Philip I, Clapisson G, Bendriss Vermare N, Menetrier Caux C, Sebban C, Biron P, Blay J: CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer. Cancer. 2004, 101: 2675-2680. 10.1002\/cncr.20688.","journal-title":"Cancer"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-4-34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-8722-4-34\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-4-34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T08:54:09Z","timestamp":1592816049000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/1756-8722-4-34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1186\/1756-8722-4-34","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,15]]},"article-number":"34"}}